These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 28377552

  • 1. Inhaled long-acting bronchodilators for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):e64-e65. PubMed ID: 28377552
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drugs for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):57-62. PubMed ID: 28377550
    [No Abstract] [Full Text] [Related]

  • 5. Future of chronic obstructive pulmonary disease management.
    D'Urzo A, Vogelmeier C.
    Expert Rev Respir Med; 2012 Jun 10; 6(3):285-99. PubMed ID: 22788943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Seebri Neohaler and Utibron Neohaler for COPD.
    Med Lett Drugs Ther; 2016 Mar 28; 58(1491):39-41. PubMed ID: 27027687
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A review of nebulized drug delivery in COPD.
    Tashkin DP.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 28; 11():2585-2596. PubMed ID: 27799757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N, Wang C, Zhou X, Zhang N, Humphries M, Wang L, Thach C, Patalano F, Banerji D, LANTERN Investigators.
    Int J Chron Obstruct Pulmon Dis; 2015 Mar 28; 10():1015-26. PubMed ID: 26082625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
    Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J.
    Int J Chron Obstruct Pulmon Dis; 2017 Mar 28; 12():2917-2928. PubMed ID: 29062229
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Emerging inhalers in the management of COPD.
    Ball J.
    S D Med; 2015 Apr 28; 68(4):169-71. PubMed ID: 25946896
    [No Abstract] [Full Text] [Related]

  • 20. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr 28; 11():1403-11. PubMed ID: 27382276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.